Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preferences considered first time fda decision approve first kind obesity
… engaging with national, regional, and local payers, payer decision-makers, and HTA agencies (e.g., private insurers, … need to clearly communicate to payers, prescribers, and patient advocates the unique value provided by your products. … national, regional, and local payers, prescribers, and patient advocates. Field Testing Health Economics Models with …
… within the Medicare system is becoming a reality. The first 10 drugs have been selected for the new Medicare Drug …
… projects have included: Benefit-risk preference studies Decision-analytic models (cost effectiveness, budget impact) … Global Value Dossiers Literature reviews Measurement of patient preferences for treatment options Observational studies …
… includes all technology, products, and services used for patient care, treatment, diagnosis, monitoring, or health …
… have included: Database analyses using claims and EMR data Decision-analytic models (cost effectiveness, budget impact) … quality-of-life analyses Literature reviews Measurement of patient preferences for treatment options Meta-analysis studies …
… program—from market access, outcomes research, patient preference, and economic evaluation, to reimbursement …
… treatment strategies on the 12-year risk of dementia. The first two strategies involved the initiation of … Weighting Exposure assignment and Eligibility at time zero An active comparator was included to reduce … by including inverse probability weighting to adjust for time-varying confounders. Both treatment assignment and the …
… the effect of treatment strategies that are sustained over time is not straightforward, because only people who live for a long time can receive treatment for a long time. A way to … manage this potential for immortal time bias consists of, first, cloning your observational data set into as many …
… experts will be presented at the SIRS 2023 Congress. Preferences for characteristics of oral antipsychotic …
… C , Panchmatia HR, Gasper S, Citrome L, Sajatovic M. Preferences for characteristics of oral antipsychotic …